word,tfidf
m12,0.316493813584769
m6,0.242798073689904
m3,0.21665058883099125
response,0.2138955859712898
week,0.1762601493025151
m24,0.17301661809300709
12,0.17230477758798346
treatment,0.14853860136895125
criteria,0.1197238749979348
m1,0.11953135935502966
rate,0.118830881095161
24,0.11586010906778196
grade,0.10991856501302391
m0,0.10971785537605327
baseline,0.10309555902599941
incidence,0.10309555902599941
assessed,0.10100624893088685
relapse,0.0950647048761288
inclusion,0.09209393284874978
16,0.0897929062484511
days,0.08912316082137074
following,0.08318161676661269
disease,0.08318161676661269
events,0.08021084473923368
score,0.07981591666528987
estimated,0.07844245457673822
gvhd,0.07724007271185465
remission,0.07724007271185465
trsae,0.07700758602709354
evaluated,0.07649025347090278
month,0.07649025347090278
endpoint,0.07649025347090278
survival,0.07426930068447563
primary,0.07426930068447563
complete,0.07426930068447563
48,0.07316459027651571
infusion,0.07316459027651571
compared,0.07316459027651571
priors,0.07250824202906699
m9,0.07173859774588098
analysis,0.0712985286570966
overall,0.06832775662971757
adverse,0.06832775662971757
safety,0.06832775662971757
informative,0.0675186802314174
21,0.06723638963720419
hospitalization,0.06651326388774156
post,0.06535698460233855
progression,0.06535698460233855
severe,0.062386212574959514
improvement,0.05976567967751483
22,0.05976567967751483
bilag,0.059078845202490224
changes,0.059078845202490224
mrss,0.05775568952032015
beta,0.05603032469767016
w25,0.05577557079158999
arm,0.05347389649282245
cells,0.05347389649282245
toxicity,0.05347389649282245
lesions,0.05347389649282245
life,0.05347389649282245
36,0.05321061111019324
cdeis,0.0529427153936268
quality,0.05050312446544342
acute,0.05050312446544342
w48,0.05019801371243099
mean,0.049884947915806166
prednisone,0.049884947915806166
analyses,0.048559614737980795
ctcae,0.048559614737980795
normalization,0.04812974126693346
troubles,0.04812974126693346
weeks,0.0475323524380644
health,0.0475323524380644
failure,0.0475323524380644
function,0.046559284721419084
100,0.046559284721419084
msc,0.046559284721419084
proteinuria,0.04641909265909946
models,0.04482425975813612
cardiac,0.04456158041068537
cell,0.04456158041068537
disappearance,0.04331676714024011
endpoints,0.04323362152703201
parameters,0.04323362152703201
actg,0.04219917514463587
questionnaire,0.04219917514463587
prevalence,0.04219917514463587
follow,0.041590808383306345
transplantation,0.041590808383306345
best,0.041590808383306345
mri,0.04108890477829145
evaluation,0.03990795833264493
25,0.03990795833264493
efficacy,0.03990795833264493
free,0.03990795833264493
occurrence,0.03990795833264493
ileocolonoscopies,0.03904289955411299
estimator,0.03904289955411299
injection,0.038620036355927326
increase,0.038620036355927326
20,0.038620036355927326
model,0.038620036355927326
transplant,0.038620036355927326
secondary,0.038620036355927326
chronic,0.038620036355927326
reappearance,0.03850379301354677
pga,0.037979257630172285
bayesian,0.037979257630172285
ventricular,0.037979257630172285
creatinine,0.037353549798446774
clinically,0.037353549798446774
platelets,0.037353549798446774
repeated,0.037353549798446774
infusions,0.03658229513825786
sae,0.0337593401157087
cost,0.0337593401157087
equal,0.0337593401157087
grading,0.03369081888685342
uniform,0.03369081888685342
imaging,0.03361819481860209
w55,0.03361819481860209
worsening,0.03361819481860209
consecutive,0.03361819481860209
arms,0.03361819481860209
v5,0.033465342474953995
appearance,0.033465342474953995
phd,0.033465342474953995
credible,0.033465342474953995
percentage,0.03325663194387078
change,0.03325663194387078
effect,0.03325663194387078
10,0.032678492301169274
considered,0.032678492301169274
vasculitis,0.032678492301169274
retinal,0.032678492301169274
normal,0.0299309687494837
central,0.0299309687494837
classification,0.0299309687494837
partial,0.0299309687494837
vascular,0.0299309687494837
decrease,0.0299309687494837
left,0.029882839838757416
measured,0.029882839838757416
hours,0.029882839838757416
described,0.029882839838757416
cumulative,0.029882839838757416
30,0.02970772027379025
anti,0.02970772027379025
eye,0.02970772027379025
mg,0.02970772027379025
treatments,0.02970772027379025
end,0.02970772027379025
sf,0.029539422601245112
binomial,0.029539422601245112
dlco,0.028877844760160074
density,0.028877844760160074
alive,0.028877844760160074
impairment,0.027887785395794996
biologically,0.027887785395794996
linear,0.027887785395794996
reading,0.027887785395794996
event,0.026736948246411225
activity,0.026736948246411225
date,0.026736948246411225
specific,0.026736948246411225
chimerism,0.026736948246411225
levels,0.026736948246411225
involvement,0.026736948246411225
tumor,0.02660530555509662
serum,0.02660530555509662
ssc,0.02660530555509662
appendix,0.02660530555509662
visit,0.02660530555509662
neutrophils,0.02660530555509662
laboratory,0.02660530555509662
renal,0.02614748485891274
analyzed,0.02614748485891274
stopping,0.02614748485891274
maximum,0.02614748485891274
w36,0.025319505086781526
glomerular,0.025319505086781526
fvc,0.025319505086781526
w24,0.025319505086781526
ct,0.025319505086781526
markers,0.025319505086781526
scan,0.025319505086781526
random,0.025319505086781526
w12,0.025319505086781526
abnormalities,0.02406487063346673
thickness,0.02406487063346673
filtration,0.02406487063346673
centralized,0.02406487063346673
m4,0.02406487063346673
ae,0.02406487063346673
reactive,0.02406487063346673
meier,0.02406487063346673
kaplan,0.02406487063346673
segmental,0.02406487063346673
early,0.0237661762190322
probability,0.0237661762190322
assessment,0.0237661762190322
level,0.0237661762190322
ii,0.0237661762190322
increased,0.0237661762190322
randomization,0.0237661762190322
independent,0.0237661762190322
immune,0.0237661762190322
therapy,0.0237661762190322
19,0.0237661762190322
transfusion,0.023279642360709542
proportion,0.023279642360709542
haze,0.023279642360709542
index,0.023279642360709542
cancer,0.023279642360709542
engraftment,0.023279642360709542
nk,0.023279642360709542
recorded,0.02241212987906806
section,0.02241212987906806
criterion,0.02241212987906806
account,0.02241212987906806
occurs,0.02241212987906806
lymphocytes,0.02241212987906806
flare,0.02241212987906806
expression,0.02241212987906806
pcr,0.02241212987906806
documented,0.02241212987906806
observations,0.02241212987906806
measurements,0.022310228316635993
recist,0.022310228316635993
organization,0.022310228316635993
unblinded,0.022310228316635993
nci,0.022310228316635993
scales,0.022310228316635993
rule,0.021099587572317936
w16,0.021099587572317936
w30,0.021099587572317936
w20,0.021099587572317936
protein,0.021099587572317936
rejection,0.021099587572317936
intervals,0.021099587572317936
w8,0.021099587572317936
definition,0.021099587572317936
prednisolone,0.021099587572317936
organs,0.021099587572317936
rbc,0.021099587572317936
w4,0.021099587572317936
iv,0.020795404191653172
phase,0.020795404191653172
data,0.020795404191653172
severity,0.020795404191653172
measures,0.020795404191653172
resolution,0.020795404191653172
uveitis,0.019953979166322466
cause,0.019953979166322466
absence,0.019953979166322466
requiring,0.019953979166322466
randomized,0.019953979166322466
start,0.019953979166322466
graft,0.019953979166322466
24h,0.019251896506773385
toxic,0.019251896506773385
w13,0.019251896506773385
gastrointestinal,0.019251896506773385
globally,0.019251896506773385
shaq,0.019251896506773385
ctae,0.019251896506773385
nih,0.019251896506773385
stabilization,0.019251896506773385
anonymous,0.019251896506773385
attacks,0.019251896506773385
magic,0.019251896506773385
md,0.019251896506773385
mdrd,0.019251896506773385
mcr,0.019251896506773385
endoscopic,0.018676774899223387
lung,0.018676774899223387
reconstitution,0.018676774899223387
clearance,0.018676774899223387
blinded,0.018676774899223387
target,0.018676774899223387
composite,0.018676774899223387
gamma,0.018676774899223387
dna,0.018676774899223387
steroids,0.01782463216427415
samples,0.01782463216427415
second,0.01782463216427415
death,0.01782463216427415
evolution,0.01782463216427415
pre,0.01782463216427415
active,0.01782463216427415
kg,0.01782463216427415
infections,0.01782463216427415
corticosteroid,0.01782463216427415
value,0.01782463216427415
cns,0.01687967005785435
world,0.01687967005785435
digestive,0.01687967005785435
physician,0.01687967005785435
cd8,0.01687967005785435
min,0.01687967005785435
cd4,0.01687967005785435
survey,0.01687967005785435
rank,0.01687967005785435
stenosis,0.01687967005785435
tested,0.01687967005785435
features,0.01687967005785435
borr,0.01687967005785435
distribution,0.01687967005785435
degree,0.01687967005785435
physical,0.01687967005785435
tolerability,0.01687967005785435
ferritin,0.01687967005785435
d60,0.01687967005785435
capacity,0.01687967005785435
segment,0.01687967005785435
chest,0.01687967005785435
magnetic,0.01687967005785435
resonance,0.01687967005785435
women,0.01687967005785435
leukemic,0.016732671237476997
manifestation,0.016732671237476997
ulcerations,0.016732671237476997
distributions,0.016732671237476997
10000,0.016732671237476997
47,0.016732671237476997
intercept,0.016732671237476997
conclude,0.016732671237476997
qaly,0.016732671237476997
addenda,0.016732671237476997
consortium,0.016732671237476997
confirmed,0.01662831597193539
monitoring,0.01662831597193539
ks,0.01662831597193539
bd,0.01662831597193539
use,0.01662831597193539
m2,0.01662831597193539
mortality,0.01662831597193539
transfusions,0.01662831597193539
platelet,0.01662831597193539
tolerance,0.01662831597193539
body,0.01662831597193539
skin,0.01662831597193539
status,0.01662831597193539
symptoms,0.01662831597193539
having,0.01662831597193539
interaction,0.01662831597193539
scale,0.01662831597193539
antibiotic,0.01662831597193539
included,0.01662831597193539
surface,0.014941419919378708
biological,0.014941419919378708
decreased,0.014941419919378708
hemolytic,0.014941419919378708
scores,0.014941419919378708
moderate,0.014941419919378708
pulmonary,0.014941419919378708
cd,0.014941419919378708
reduced,0.014941419919378708
al,0.014941419919378708
chosen,0.014941419919378708
lymphocyte,0.014941419919378708
difference,0.014941419919378708
point,0.014941419919378708
discontinuation,0.014941419919378708
beginning,0.014941419919378708
95,0.014941419919378708
tolerated,0.014941419919378708
toxicities,0.014941419919378708
concentration,0.014941419919378708
cerebral,0.014941419919378708
kidney,0.014941419919378708
nervous,0.014941419919378708
vitreous,0.014853860136895125
hsct,0.014853860136895125
year,0.014853860136895125
peripheral,0.014853860136895125
count,0.014853860136895125
infection,0.014853860136895125
50,0.014853860136895125
collection,0.014853860136895125
risk,0.014853860136895125
period,0.014853860136895125
medical,0.014853860136895125
behcets,0.014853860136895125
posterior,0.014853860136895125
60,0.014853860136895125
test,0.014853860136895125
syndrome,0.014853860136895125
observed,0.014853860136895125
ckd,0.014438922380080037
w5,0.014438922380080037
36v2,0.014438922380080037
5d,0.014438922380080037
delay,0.014438922380080037
troponin,0.014438922380080037
eq,0.014438922380080037
pains,0.014438922380080037
aes,0.014438922380080037
analyzing,0.014438922380080037
budesonide,0.014438922380080037
percent,0.014438922380080037
epi,0.014438922380080037
abdominal,0.014438922380080037
d100,0.014438922380080037
exam,0.014438922380080037
titers,0.014438922380080037
preinclusion,0.014438922380080037
il,0.014438922380080037
log,0.014438922380080037
market,0.014438922380080037
achieving,0.014438922380080037
short,0.014438922380080037
stock,0.014438922380080037
mra,0.014438922380080037
visual,0.01330265277754831
previous,0.01330265277754831
frequency,0.01330265277754831
sparing,0.01330265277754831
need,0.01330265277754831
visits,0.01330265277754831
red,0.01330265277754831
usual,0.01330265277754831
different,0.01330265277754831
collected,0.01330265277754831
presence,0.01330265277754831
et,0.01330265277754831
neutrophil,0.01330265277754831
international,0.01330265277754831
considering,0.01330265277754831
course,0.01330265277754831
covid,0.01330265277754831
allogeneic,0.01330265277754831
cmv,0.012659752543390763
discretion,0.012659752543390763
5l,0.012659752543390763
dsmb,0.012659752543390763
echocardiography,0.012659752543390763
arthritis,0.012659752543390763
recurrence,0.012659752543390763
mass,0.012659752543390763
rules,0.012659752543390763
clinic,0.012659752543390763
sub,0.012659752543390763
ctc,0.012659752543390763
myeloid,0.012659752543390763
neutropenia,0.012659752543390763
quantification,0.012659752543390763
microns,0.012659752543390763
continuous,0.012659752543390763
creatininuria,0.012659752543390763
targets,0.012659752543390763
numbers,0.012659752543390763
oct,0.012659752543390763
preexisting,0.012659752543390763
terminology,0.012659752543390763
pain,0.012659752543390763
detection,0.012659752543390763
refractory,0.0118830881095161
interval,0.0118830881095161
donor,0.0118830881095161
rates,0.0118830881095161
ocular,0.0118830881095161
systemic,0.0118830881095161
plasma,0.0118830881095161
associated,0.0118830881095161
macular,0.0118830881095161
duration,0.0118830881095161
set,0.01120606493953403
reasons,0.01120606493953403
real,0.01120606493953403
sample,0.01120606493953403
crp,0.01120606493953403
impact,0.01120606493953403
interim,0.01120606493953403
optical,0.01120606493953403
allo,0.01120606493953403
investigator,0.01120606493953403
300,0.01120606493953403
initiation,0.01120606493953403
180,0.01120606493953403
biopsy,0.01120606493953403
deterioration,0.01120606493953403
qol,0.01120606493953403
cure,0.01120606493953403
cycle,0.01120606493953403
bcva,0.01120606493953403
grfs,0.01120606493953403
treat,0.01120606493953403
define,0.01120606493953403
underlying,0.01120606493953403
unacceptable,0.01120606493953403
common,0.01120606493953403
immunological,0.01120606493953403
values,0.01120606493953403
virological,0.01120606493953403
voc,0.01120606493953403
version,0.01120606493953403
objective,0.01120606493953403
bone,0.01120606493953403
wbc,0.01120606493953403
weight,0.01120606493953403
ebv,0.01120606493953403
respectively,0.01120606493953403
tomography,0.01120606493953403
final,0.01120606493953403
absolute,0.01120606493953403
profile,0.01120606493953403
positive,0.01120606493953403
meeting,0.01120606493953403
extra,0.01120606493953403
coherence,0.01120606493953403
lower,0.01120606493953403
jy,0.011155114158317997
140,0.011155114158317997
10mg,0.011155114158317997
endocrinal,0.011155114158317997
covid19,0.011155114158317997
207,0.011155114158317997
214,0.011155114158317997
rectal,0.011155114158317997
seen,0.011155114158317997
ekg,0.011155114158317997
ophthalmological,0.011155114158317997
scleroderma,0.011155114158317997
remissions,0.011155114158317997
doubling,0.011155114158317997
doubled,0.011155114158317997
1g,0.011155114158317997
correlations,0.011155114158317997
articular,0.011155114158317997
superficial,0.011155114158317997
gained,0.011155114158317997
gammaglobulines,0.011155114158317997
aggravation,0.011155114158317997
38,0.011155114158317997
triggered,0.011155114158317997
estimations,0.011155114158317997
osseous,0.011155114158317997
osteoporosis,0.011155114158317997
ulcers,0.011155114158317997
lasting,0.011155114158317997
logistic,0.011155114158317997
hematuria,0.011155114158317997
curve,0.011155114158317997
ctep,0.011155114158317997
productivity,0.011155114158317997
territory,0.011155114158317997
mast,0.011155114158317997
miller,0.011155114158317997
d1,0.011155114158317997
surrogate,0.011155114158317997
avoided,0.011155114158317997
1981,0.011155114158317997
diffusing,0.011155114158317997
diseappearance,0.011155114158317997
dysmetabolic,0.011155114158317997
diet,0.011155114158317997
dysfunctions,0.011155114158317997
novo,0.011155114158317997
neurologic,0.011155114158317997
nephritis,0.011155114158317997
neurological,0.009976989583161233
chamber,0.009976989583161233
manifestations,0.009976989583161233
right,0.009976989583161233
inflammatory,0.009976989583161233
inflammation,0.009976989583161233
hla,0.009976989583161233
hospital,0.009976989583161233
reduction,0.009976989583161233
organ,0.009976989583161233
2016,0.009976989583161233
sct,0.009976989583161233
antibodies,0.009976989583161233
injected,0.009976989583161233
counts,0.009976989583161233
stage,0.009976989583161233
uninjected,0.009976989583161233
care,0.009976989583161233
effects,0.009976989583161233
onset,0.009976989583161233
18,0.009976989583161233
calculated,0.009976989583161233
low,0.009976989583161233
follows,0.009976989583161233
presented,0.009976989583161233
sle,0.009976989583161233
sun,0.009976989583161233
populations,0.009625948253386692
angio,0.009625948253386692
c2d1,0.009625948253386692
finally,0.009625948253386692
cytometry,0.009625948253386692
d15,0.009625948253386692
dyslipidemia,0.009625948253386692
neuropathy,0.009625948253386692
thoracic,0.009625948253386692
result,0.009625948253386692
courses,0.009625948253386692
velocity,0.009625948253386692
hospitalized,0.009625948253386692
siti,0.009625948253386692
orr,0.009625948253386692
monoxide,0.009625948253386692
ileocolonoscopy,0.009625948253386692
censored,0.009625948253386692
enhancement,0.009625948253386692
carbon,0.009625948253386692
rennes,0.009625948253386692
cardiovascular,0.009625948253386692
anc,0.009625948253386692
aplasia,0.009625948253386692
electrolytes,0.009625948253386692
scored,0.009625948253386692
segments,0.009625948253386692
copies,0.009625948253386692
hrqol,0.009625948253386692
muscular,0.009625948253386692
neoplasia,0.009625948253386692
med,0.009625948253386692
standards,0.009625948253386692
collaboration,0.009625948253386692
accompanied,0.009625948253386692
excluding,0.009625948253386692
tricuspid,0.009625948253386692
tyndall,0.009625948253386692
tnfa,0.009625948253386692
d45,0.009625948253386692
deep,0.009625948253386692
grcs,0.009625948253386692
gadolinium,0.009625948253386692
ansm,0.009625948253386692
lymphedema,0.009625948253386692
lethargy,0.009625948253386692
multi,0.009625948253386692
bn,0.009625948253386692
equation,0.009625948253386692
episode,0.009625948253386692
quantitative,0.009625948253386692
lvef,0.009625948253386692
blinding,0.009625948253386692
gt,0.009625948253386692
ps,0.009625948253386692
esr,0.009625948253386692
intent,0.009625948253386692
edema,0.008912316082137075
previously,0.008912316082137075
treated,0.008912316082137075
main,0.008912316082137075
potential,0.008912316082137075
sars,0.008912316082137075
cryoglobulinemia,0.008912316082137075
anterior,0.008912316082137075
amplification,0.008912316082137075
daily,0.008912316082137075
prca,0.008912316082137075
evidence,0.008912316082137075
total,0.008912316082137075
250,0.008439835028927175
diabetes,0.008439835028927175
fertility,0.008439835028927175
tarte,0.008439835028927175
tests,0.008439835028927175
phosphatase,0.008439835028927175
cervical,0.008439835028927175
bilateral,0.008439835028927175
bilirubin,0.008439835028927175
metabolic,0.008439835028927175
mild,0.008439835028927175
paraclinical,0.008439835028927175
men,0.008439835028927175
150,0.008439835028927175
infiltration,0.008439835028927175
angiography,0.008439835028927175
whichever,0.008439835028927175
fever,0.008439835028927175
sponsor,0.008439835028927175
sri,0.008439835028927175
qlq,0.008439835028927175
gammaglobulin,0.008439835028927175
d29,0.008439835028927175
forced,0.008439835028927175
check,0.008439835028927175
m15,0.008439835028927175
maintenance,0.008439835028927175
chelation,0.008439835028927175
acquired,0.008439835028927175
unique,0.008439835028927175
gov,0.008439835028927175
complement,0.008439835028927175
stored,0.008439835028927175
adherence,0.008439835028927175
extensive,0.008439835028927175
affected,0.008439835028927175
statistics,0.008439835028927175
length,0.008439835028927175
leakage,0.008439835028927175
questionnaires,0.008439835028927175
epidemiology,0.008439835028927175
eortc,0.008439835028927175
hemoglobin,0.008439835028927175
average,0.008439835028927175
description,0.008439835028927175
radiological,0.008439835028927175
assay,0.008439835028927175
reaction,0.008439835028927175
keytruda,0.008439835028927175
reactants,0.008439835028927175
enzymes,0.008439835028927175
sign,0.008439835028927175
sequentially,0.008439835028927175
criss,0.008439835028927175
ms,0.008439835028927175
v3,0.008439835028927175
urine,0.008439835028927175
alkaline,0.008439835028927175
hhv8,0.008439835028927175
consider,0.008439835028927175
effectiveness,0.008439835028927175
c30,0.008439835028927175
c4,0.008439835028927175
doppler,0.008439835028927175
du,0.008439835028927175
immunosuppression,0.008439835028927175
safe,0.008439835028927175
volume,0.008439835028927175
zero,0.008439835028927175
candidate,0.007470709959689354
01,0.007470709959689354
negative,0.007470709959689354
enrolled,0.007470709959689354
corrected,0.007470709959689354
mmol,0.007470709959689354
cov,0.007470709959689354
responders,0.007470709959689354
ml,0.007470709959689354
expected,0.007470709959689354
fact,0.007470709959689354
500,0.007470709959689354
estimate,0.007470709959689354
causes,0.007470709959689354
charge,0.007470709959689354
identification,0.007470709959689354
implemented,0.007470709959689354
immunosuppressive,0.007470709959689354
relapses,0.007470709959689354
consumption,0.007470709959689354
modification,0.007470709959689354
sledai,0.007470709959689354
stroke,0.007470709959689354
gene,0.007470709959689354
vital,0.007470709959689354
determined,0.007470709959689354
05,0.007470709959689354
disorders,0.007470709959689354
global,0.007470709959689354
better,0.007470709959689354
measurement,0.007470709959689354
injections,0.007470709959689354
search,0.007470709959689354
regression,0.007470709959689354
acuity,0.007470709959689354
activation,0.007470709959689354
acs,0.007470709959689354
hematological,0.007470709959689354
combined,0.007470709959689354
cytokines,0.007470709959689354
allograft,0.007470709959689354
recipient,0.007470709959689354
recommendation,0.007470709959689354
judgment,0.007470709959689354
table,0.007470709959689354
selena,0.007470709959689354
thrombosis,0.006651326388774155
required,0.006651326388774155
corticosteroids,0.006651326388774155
anemia,0.006651326388774155
costs,0.006651326388774155
55,0.006651326388774155
ensure,0.006651326388774155
unit,0.006651326388774155
measure,0.006651326388774155
marrow,0.006651326388774155
aiec,0.006651326388774155
regulatory,0.006651326388774155
investigators,0.006651326388774155
refer,0.006651326388774155
reference,0.006651326388774155
biopsies,0.006651326388774155
terms,0.006651326388774155
iii,0.006651326388774155
antibody,0.006651326388774155
pembrolizumab,0.006651326388774155
paris,0.006651326388774155
performance,0.006651326388774155
perform,0.006651326388774155
points,0.006651326388774155
heart,0.006651326388774155
factors,0.006651326388774155
support,0.006651326388774155
assess,0.006651326388774155
taken,0.006651326388774155
allow,0.006651326388774155
present,0.006651326388774155
line,0.006651326388774155
limited,0.006651326388774155
loss,0.006651326388774155
approach,0.006651326388774155
committee,0.006651326388774155
liver,0.006651326388774155
viral,0.006651326388774155
17,0.006651326388774155
vessel,0.00594154405475805
doses,0.00594154405475805
step,0.00594154405475805
additional,0.00594154405475805
current,0.00594154405475805
complications,0.00594154405475805
steroid,0.00594154405475805
hematopoietic,0.00594154405475805
optimal,0.00594154405475805
includes,0.00594154405475805
modified,0.00594154405475805
capmatinib,0.00594154405475805
adapted,0.00594154405475805
placebo,0.00594154405475805
group,0.00594154405475805
administration,0.00594154405475805
greater,0.00594154405475805
vincent,0.005577557079158998
discussion,0.005577557079158998
dlqi,0.005577557079158998
echocardiographies,0.005577557079158998
economic,0.005577557079158998
electronic_applications,0.005577557079158998
dimension,0.005577557079158998
dhtr,0.005577557079158998
dialysis,0.005577557079158998
cytof,0.005577557079158998
cylinders,0.005577557079158998
specify,0.005577557079158998
eac,0.005577557079158998
dyspnea,0.005577557079158998
occurence,0.005577557079158998
carriage,0.005577557079158998
cardiological,0.005577557079158998
location,0.005577557079158998
avascular,0.005577557079158998
qql,0.005577557079158998
qualified,0.005577557079158998
quantified,0.005577557079158998
ctc_50,0.005577557079158998
variation,0.005577557079158998
veino,0.005577557079158998
1999,0.005577557079158998
105,0.005577557079158998
oliguria,0.005577557079158998
vd,0.005577557079158998
doesnt,0.005577557079158998
2007,0.005577557079158998
1b,0.005577557079158998
36v2tm,0.005577557079158998
luminex,0.005577557079158998
strips,0.005577557079158998
colitis,0.005577557079158998
cmax,0.005577557079158998
protocoldevelopment,0.005577557079158998
przepiorka,0.005577557079158998
haut,0.005577557079158998
attributable,0.005577557079158998
adjudicated,0.005577557079158998
adding,0.005577557079158998
arthralgia,0.005577557079158998
hemoglobinuria,0.005577557079158998
gut,0.005577557079158998
quantity,0.005577557079158998
jb,0.005577557079158998
jp,0.005577557079158998
d42,0.005577557079158998
supervisor,0.005577557079158998
subset,0.005577557079158998
prob,0.005577557079158998
bdca,0.005577557079158998
chevret,0.005577557079158998
false,0.005577557079158998
simultaneously,0.005577557079158998
sh,0.005577557079158998
sf36v2,0.005577557079158998
alloantibodies,0.005577557079158998
histological,0.005577557079158998
height,0.005577557079158998
gobal,0.005577557079158998
john,0.005577557079158998
jet,0.005577557079158998
kdigo2012,0.005577557079158998
kit,0.005577557079158998
accurate,0.005577557079158998
cytotoxicity,0.005577557079158998
banked,0.005577557079158998
practices,0.005577557079158998
cytology,0.005577557079158998
fracture,0.005577557079158998
cl,0.005577557079158998
city,0.005577557079158998
circumference,0.005577557079158998
hermine,0.005577557079158998
albumin,0.005577557079158998
sclicc,0.005577557079158998
polymerase,0.005577557079158998
mar,0.005577557079158998
regurgitation,0.005577557079158998
ileitis,0.005577557079158998
regurgitant,0.005577557079158998
regress,0.005577557079158998
telomere,0.005577557079158998
inverse,0.005577557079158998
fitting,0.005577557079158998
far,0.005577557079158998
chain,0.005577557079158998
mediator,0.005577557079158998
ped,0.005577557079158998
pdl1,0.005577557079158998
recall,0.005577557079158998
aspects,0.005577557079158998
globule,0.005577557079158998
foster,0.005577557079158998
characterization,0.005577557079158998
medullary,0.005577557079158998
methodology,0.005577557079158998
pbmcs,0.005577557079158998
painful,0.005577557079158998
paxgene,0.005577557079158998
panels,0.005577557079158998
patientsfiles,0.005577557079158998
roth,0.005577557079158998
htm,0.005577557079158998
immunoglobulin,0.005577557079158998
imagine,0.005577557079158998
annexe,0.005577557079158998
packed,0.005577557079158998
amh,0.005577557079158998
rouge,0.005577557079158998
million,0.005577557079158998
bsas,0.005577557079158998
bosch,0.005577557079158998
bonne,0.005577557079158998
absolue,0.005577557079158998
99,0.005577557079158998
explicit,0.005577557079158998
experiencing,0.005577557079158998
exhaustion,0.005577557079158998
75015,0.005577557079158998
73,0.005577557079158998
tmax,0.005577557079158998
tm,0.005577557079158998
aphtoid,0.005577557079158998
aom,0.005577557079158998
mo,0.005577557079158998
transcripts,0.005577557079158998
declared,0.005577557079158998
excellence,0.005577557079158998
establish,0.005577557079158998
montparnasse,0.005577557079158998
revised,0.005577557079158998
mrt,0.005577557079158998
52,0.005577557079158998
reticulocytopenia,0.005577557079158998
residence,0.005577557079158998
indicative,0.005577557079158998
indices,0.005577557079158998
annals,0.005577557079158998
imputable,0.005577557079158998
retinopathy,0.005577557079158998
morality,0.005577557079158998
cd56,0.005577557079158998
centered,0.005577557079158998
dermatology,0.005577557079158998
cd3,0.005577557079158998
densities,0.005577557079158998
unlikely,0.005577557079158998
ordinal,0.005577557079158998
variance,0.005577557079158998
optimizing,0.005577557079158998
oozing,0.005577557079158998
california,0.005577557079158998
necessarily,0.005577557079158998
107,0.005577557079158998
calprotectin,0.005577557079158998
130,0.005577557079158998
zhang,0.005577557079158998
1000,0.004812974126693346
efficiency,0.004812974126693346
edge,0.004812974126693346
ebmt,0.004812974126693346
27,0.004812974126693346
variants,0.004812974126693346
variable,0.004812974126693346
van,0.004812974126693346
v1,0.004812974126693346
uti,0.004812974126693346
desire,0.004812974126693346
designs,0.004812974126693346
myocardial,0.004812974126693346
myelitis,0.004812974126693346
oestrogen,0.004812974126693346
occlusive,0.004812974126693346
obtaining,0.004812974126693346
normalized,0.004812974126693346
neutrophiles,0.004812974126693346
mos,0.004812974126693346
mononeuropathy,0.004812974126693346
cdai,0.004812974126693346
opioid,0.004812974126693346
oncology,0.004812974126693346
olivier,0.004812974126693346
called,0.004812974126693346
negativation,0.004812974126693346
necker,0.004812974126693346
nausea,0.004812974126693346
encephalitis,0.004812974126693346
unconsciousness,0.004812974126693346
unaffected,0.004812974126693346
ulceration,0.004812974126693346
5ml,0.004812974126693346
5mg,0.004812974126693346
estimates,0.004812974126693346
moment,0.004812974126693346
mmhg,0.004812974126693346
minimize,0.004812974126693346
brutal,0.004812974126693346
boulevard,0.004812974126693346
ovarian,0.004812974126693346
episodes,0.004812974126693346
3mg,0.004812974126693346
38c,0.004812974126693346
ulcerated,0.004812974126693346
trv,0.004812974126693346
true,0.004812974126693346
ex,0.004812974126693346
demonstrated,0.004812974126693346
parity,0.004812974126693346
pancytopenia,0.004812974126693346
bvas,0.004812974126693346
dedicated,0.004812974126693346
transverse,0.004812974126693346
transthoracic,0.004812974126693346
transfused,0.004812974126693346
transformed,0.004812974126693346
transferrin,0.004812974126693346
tp,0.004812974126693346
extracted,0.004812974126693346
expressed,0.004812974126693346
expert,0.004812974126693346
expect,0.004812974126693346
80c,0.004812974126693346
73m2,0.004812974126693346
72,0.004812974126693346
tomographic,0.004812974126693346
cessation,0.004812974126693346
biobanking,0.004812974126693346
persistence,0.004812974126693346
permanent,0.004812974126693346
pd1,0.004812974126693346
microg,0.004812974126693346
testosterone,0.004812974126693346
film,0.004812974126693346
fecal,0.004812974126693346
febrile,0.004812974126693346
fatigue,0.004812974126693346
failures,0.004812974126693346
accounting,0.004812974126693346
accordingly,0.004812974126693346
swab,0.004812974126693346
d0,0.004812974126693346
cytopenia,0.004812974126693346
fluorescein,0.004812974126693346
phenotypes,0.004812974126693346
pharmacodynamic,0.004812974126693346
chapter,0.004812974126693346
functioning,0.004812974126693346
fulfilled,0.004812974126693346
fsh,0.004812974126693346
supervision,0.004812974126693346
sum,0.004812974126693346
suffering,0.004812974126693346
substance,0.004812974126693346
subsequent,0.004812974126693346
submitted,0.004812974126693346
combining,0.004812974126693346
possibly,0.004812974126693346
pneumonitis,0.004812974126693346
meaning,0.004812974126693346
stevens,0.004812974126693346
adjusted,0.004812974126693346
gonadic,0.004812974126693346
glomerulonephritis,0.004812974126693346
gastroenterology,0.004812974126693346
gastrectomy,0.004812974126693346
adjudication,0.004812974126693346
standardized,0.004812974126693346
st,0.004812974126693346
spermogram,0.004812974126693346
specimens,0.004812974126693346
hads,0.004812974126693346
lost,0.004812974126693346
hematocrit,0.004812974126693346
hemagglutinins,0.004812974126693346
hcsp,0.004812974126693346
cytogenetic,0.004812974126693346
sp02,0.004812974126693346
sonography,0.004812974126693346
snellen,0.004812974126693346
settings,0.004812974126693346
alterations,0.004812974126693346
agreement,0.004812974126693346
crohns,0.004812974126693346
ib,0.004812974126693346
immunophenotyping,0.004812974126693346
immunomodulation,0.004812974126693346
immunology,0.004812974126693346
ileum,0.004812974126693346
crt,0.004812974126693346
scientific,0.004812974126693346
schemes,0.004812974126693346
saturation,0.004812974126693346
compute,0.004812974126693346
auricular,0.004812974126693346
progressive,0.004812974126693346
lowest,0.004812974126693346
corpuscular,0.004812974126693346
incorporating,0.004812974126693346
incidences,0.004812974126693346
amenorrhea,0.004812974126693346
rnaemia,0.004812974126693346
reviewed,0.004812974126693346
reticulocyte,0.004812974126693346
rest,0.004812974126693346
respect,0.004812974126693346
resection,0.004812974126693346
infiltrate,0.004812974126693346
laboratoire,0.004812974126693346
knowledge,0.004812974126693346
questionaire,0.004812974126693346
lh,0.004812974126693346
apparition,0.004812974126693346
internet,0.004812974126693346
internal,0.004812974126693346
intercurrent,0.004812974126693346
recoveries,0.004812974126693346
intra,0.004812974126693346
interruption,0.004812974126693346
record,0.004812974126693346
reason,0.004812974126693346
reactivations,0.004812974126693346
aspiration,0.004812974126693346
aseptic,0.004812974126693346
keratitis,0.004812974126693346
kawasaki,0.004812974126693346
journal,0.004812974126693346
isolated,0.004812974126693346
ratios,0.004812974126693346
comorbidities,0.004812974126693346
lee,0.004812974126693346
ldh,0.004812974126693346
vomiting,0.004812974126693346
vfq,0.004812974126693346
discontinue,0.004812974126693346
dilatation,0.004812974126693346
droplet,0.004812974126693346
nerve,0.004812974126693346
vod,0.004812974126693346
2009,0.004812974126693346
1mg,0.004812974126693346
walk,0.004812974126693346
109,0.004219917514463587
120,0.004219917514463587
white,0.004219917514463587
vs,0.004219917514463587
efficient,0.004219917514463587
development,0.004219917514463587
v4,0.004219917514463587
necrosis,0.004219917514463587
depending,0.004219917514463587
updated,0.004219917514463587
uln,0.004219917514463587
cd19,0.004219917514463587
carried,0.004219917514463587
minor,0.004219917514463587
joint,0.004219917514463587
area,0.004219917514463587
approximately,0.004219917514463587
applied,0.004219917514463587
radiotherapy,0.004219917514463587
comorbidity,0.004219917514463587
lesion,0.004219917514463587
osteonecrosis,0.004219917514463587
eq5d,0.004219917514463587
details,0.004219917514463587
tubes,0.004219917514463587
exclusion,0.004219917514463587
microalbuminuria,0.004219917514463587
intensive,0.004219917514463587
recovery,0.004219917514463587
investigating,0.004219917514463587
invasive,0.004219917514463587
intravenously,0.004219917514463587
contraindication,0.004219917514463587
medullar,0.004219917514463587
medium,0.004219917514463587
charlson,0.004219917514463587
characterize,0.004219917514463587
panel,0.004219917514463587
oxygen,0.004219917514463587
c3,0.004219917514463587
decided,0.004219917514463587
deaths,0.004219917514463587
abnormality,0.004219917514463587
load,0.004219917514463587
lines,0.004219917514463587
indicating,0.004219917514463587
reporting,0.004219917514463587
anxiety,0.004219917514463587
conjugate,0.004219917514463587
abnormal,0.004219917514463587
ab,0.004219917514463587
85,0.004219917514463587
explored,0.004219917514463587
exploratory,0.004219917514463587
experience,0.004219917514463587
times,0.004219917514463587
ch50,0.004219917514463587
medication,0.004219917514463587
resistant,0.004219917514463587
inference,0.004219917514463587
la,0.004219917514463587
question,0.004219917514463587
ptcy,0.004219917514463587
median,0.004219917514463587
binary,0.004219917514463587
thrombocytopenia,0.004219917514463587
threshold,0.004219917514463587
targeting,0.004219917514463587
sustained,0.004219917514463587
fraction,0.004219917514463587
fixed,0.004219917514463587
circulating,0.004219917514463587
plasmapheresis,0.004219917514463587
phrc,0.004219917514463587
phenotyping,0.004219917514463587
proven,0.004219917514463587
prospective,0.004219917514463587
proportions,0.004219917514463587
correlation,0.004219917514463587
independence,0.004219917514463587
important,0.004219917514463587
aminotransferase,0.004219917514463587
room,0.004219917514463587
rodnan,0.004219917514463587
rheumatoid,0.004219917514463587
pharmacokinetics,0.004219917514463587
blind,0.004219917514463587
birads,0.004219917514463587
fresh,0.004219917514463587
success,0.004219917514463587
subpopulation,0.004219917514463587
colon,0.004219917514463587
bacteria,0.004219917514463587
illness,0.004219917514463587
sante,0.004219917514463587
sampling,0.004219917514463587
saes,0.004219917514463587
corresponding,0.004219917514463587
autoantibodies,0.004219917514463587
authorization,0.004219917514463587
auc,0.004219917514463587
atrial,0.004219917514463587
ast,0.004219917514463587
avoid,0.004219917514463587
platform,0.004219917514463587
match,0.004219917514463587
marker,0.004219917514463587
subgroups,0.004219917514463587
storage,0.004219917514463587
stopped,0.004219917514463587
air,0.004219917514463587
sedimentation,0.004219917514463587
cross,0.004219917514463587
idiopathic,0.004219917514463587
admission,0.004219917514463587
gold,0.004219917514463587
spontaneous,0.004219917514463587
growth,0.004219917514463587
longer,0.004219917514463587
logmar,0.004219917514463587
similarly,0.004219917514463587
serological,0.004219917514463587
alt,0.004219917514463587
alloimmunization,0.004219917514463587
hospitalisation,0.004219917514463587
hormonal,0.004219917514463587
profiles,0.004219917514463587
principal,0.004219917514463587
priapism,0.004219917514463587
beneficial,0.004219917514463587
basis,0.004219917514463587
chose,0.004219917514463587
chorioretinal,0.004219917514463587
malignancies,0.004219917514463587
nasal,0.004219917514463587
myocarditis,0.004219917514463587
objectives,0.004219917514463587
monoclonal,0.004219917514463587
later,0.004219917514463587
dl,0.004219917514463587
discharge,0.004219917514463587
died,0.004219917514463587
drop,0.004219917514463587
dosage,0.004219917514463587
ejection,0.004219917514463587
nephropathy,0.004219917514463587
nei,0.003735354979844677
os,0.003735354979844677
elderly,0.003735354979844677
oral,0.003735354979844677
ventilation,0.003735354979844677
detailed,0.003735354979844677
design,0.003735354979844677
occurring,0.003735354979844677
national,0.003735354979844677
note,0.003735354979844677
nomenclature,0.003735354979844677
chemotherapy,0.003735354979844677
2008,0.003735354979844677
cytokine,0.003735354979844677
gr,0.003735354979844677
hypertension,0.003735354979844677
http,0.003735354979844677
aims,0.003735354979844677
screening,0.003735354979844677
hgf,0.003735354979844677
adaptive,0.003735354979844677
genetic,0.003735354979844677
currently,0.003735354979844677
silent,0.003735354979844677
hopital,0.003735354979844677
history,0.003735354979844677
pressure,0.003735354979844677
standardization,0.003735354979844677
taking,0.003735354979844677
malignant,0.003735354979844677
fish,0.003735354979844677
pfs,0.003735354979844677
autoimmune,0.003735354979844677
team,0.003735354979844677
medicine,0.003735354979844677
require,0.003735354979844677
respiratory,0.003735354979844677
induced,0.003735354979844677
infarct,0.003735354979844677
known,0.003735354979844677
binding,0.003735354979844677
mechanical,0.003735354979844677
indexed,0.003735354979844677
collect,0.003735354979844677
french,0.003735354979844677
fully,0.003735354979844677
future,0.003735354979844677
bleeding,0.003735354979844677
biomedical,0.003735354979844677
analysed,0.003735354979844677
role,0.003735354979844677
lupus,0.003735354979844677
correlated,0.003735354979844677
authority,0.003735354979844677
sarcoma,0.003735354979844677
immunogenicity,0.003735354979844677
attributed,0.003735354979844677
immediate,0.003735354979844677
stay,0.003735354979844677
demonstrate,0.003735354979844677
participant,0.003735354979844677
twice,0.003735354979844677
detected,0.003735354979844677
rapidly,0.003735354979844677
rapid,0.003735354979844677
determine,0.003735354979844677
overlap,0.003735354979844677
depression,0.003735354979844677
2003,0.003735354979844677
106,0.003735354979844677
developed,0.003735354979844677
especially,0.003735354979844677
endemic,0.003735354979844677
erythrocyte,0.003735354979844677
bmt,0.003735354979844677
answer,0.003735354979844677
initial,0.003735354979844677
pathology,0.003735354979844677
meet,0.003735354979844677
context,0.003735354979844677
continue,0.003735354979844677
conventional,0.003735354979844677
investigational,0.003735354979844677
computed,0.003735354979844677
relative,0.003735354979844677
method,0.003735354979844677
institut,0.003735354979844677
aplastic,0.003735354979844677
eyes,0.003735354979844677
significant,0.0033256631943870776
specified,0.0033256631943870776
withdrawal,0.0033256631943870776
11,0.0033256631943870776
recommended,0.0033256631943870776
mixed,0.0033256631943870776
appropriate,0.0033256631943870776
consent,0.0033256631943870776
ileal,0.0033256631943870776
higher,0.0033256631943870776
louis,0.0033256631943870776
cycles,0.0033256631943870776
size,0.0033256631943870776
sites,0.0033256631943870776
icu,0.0033256631943870776
https,0.0033256631943870776
given,0.0033256631943870776
selection,0.0033256631943870776
hospitalizations,0.0033256631943870776
single,0.0033256631943870776
notably,0.0033256631943870776
eligibility,0.0033256631943870776
2012,0.0033256631943870776
2013,0.0033256631943870776
double,0.0033256631943870776
33,0.0033256631943870776
opinion,0.0033256631943870776
obtained,0.0033256631943870776
major,0.0033256631943870776
source,0.0033256631943870776
cyclophosphamide,0.0033256631943870776
threatening,0.0033256631943870776
flow,0.0033256631943870776
adult,0.0033256631943870776
kaposi,0.0033256631943870776
receiving,0.0033256631943870776
isatuximab,0.0033256631943870776
concerning,0.0033256631943870776
concomitant,0.0033256631943870776
exposure,0.0033256631943870776
inhibitor,0.0033256631943870776
residual,0.0033256631943870776
testing,0.0033256631943870776
family,0.0033256631943870776
syndromes,0.0033256631943870776
term,0.0033256631943870776
therapies,0.0033256631943870776
medications,0.0033256631943870776
late,0.0033256631943870776
centre,0.0033256631943870776
factor,0.0033256631943870776
surgery,0.0033256631943870776
historical,0.0033256631943870776
population,0.0033256631943870776
subject,0.0033256631943870776
mds,0.0033256631943870776
pr,0.0033256631943870776
starting,0.0033256631943870776
plan,0.0033256631943870776
review,0.0033256631943870776
comparison,0.0033256631943870776
characteristics,0.0033256631943870776
classic,0.0033256631943870776
therapeutic,0.0033256631943870776
80,0.0033256631943870776
release,0.0033256631943870776
delayed,0.0033256631943870776
report,0.0033256631943870776
cov2,0.0033256631943870776
ratio,0.0033256631943870776
overload,0.0033256631943870776
antibiotics,0.0033256631943870776
iron,0.0033256631943870776
benefit,0.002970772027379025
high,0.002970772027379025
sensitivity,0.002970772027379025
haplo,0.002970772027379025
groups,0.002970772027379025
signs,0.002970772027379025
poor,0.002970772027379025
management,0.002970772027379025
france,0.002970772027379025
information,0.002970772027379025
available,0.002970772027379025
followed,0.002970772027379025
met,0.002970772027379025
tnf,0.002970772027379025
conditioning,0.002970772027379025
reported,0.002970772027379025
decision,0.002970772027379025
recommendations,0.002970772027379025
40,0.002970772027379025
outcome,0.002970772027379025
multiple,0.002970772027379025
unrelated,0.002970772027379025
70,0.002970772027379025
validated,0.002970772027379025
ongoing,0.002970772027379025
